Conference Reports for NaTaP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

EFFICACY OF AN 8-WEEK REGIMEN OF GRAZOPREVIR PLUS ELBASVIR WITH AND WITHOUT RIBAVIRIN IN TREATMENT-NAIVE, NONCIRRHOTIC HCV GENOTYPE 1B INFECTION       Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria   John M. Vierling1, Marcelo Kugelmas2, Eric Lawitz3, Peggy Hwang4, Michael Robertson4, Janice Wahl4, Eliav Barr4,Barbara Haber4 1Baylor College of Medicine, Houston, TX, USA 2South Denver Gastroenterlogy, Englewood, CO, USA 3The Texas Liver Institute, of Texas Health Science Center, San Antonio, TX, USA 4Merck & Co., Inc., Kenilworth, NJ, USA